// App-Quantinova.ai

P2-18-08 : Inclusion of adjuvant bone-modifying agents for early breast cancer into standard clinical practice: Challenges and lessons learnt from an international collaboration

Researchers

Presenter

  • Sally Baron-Hay

Principal Investigators

  • Elisavet Theodoulou

  • Isobel Porter

  • Caroline Wilson

  • Ingunn Holen

  • Catherine Harper-Wynne

  • Janet Brown

Medical Centers

  • Royal North Shore Hospital, Sydney, Australia

  • Weston Park Hospital, Sheffield, United Kingdom

  • Sheffield Experimental Medicine Centre, Sheffield, United Kingdom

  • Kent Oncology Centre, Maidstone Tunbridge Wells NHS Trust, United Kingdom

  • University of Sheffield, Sheffield, United Kingdom

Locations

  • Australia

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved